Physician profile
Joy Brotherton
NPI 1194731604
$107,136.24
in general payments reported to CMS, 2019-2025
26 companies · $885 in 2025
The $885 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $30K · 2021: $291 · 2022: $401 · 2023: $1,060 · 2024: $10K · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,360 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,330 · Food and Beverage: $2,678 · Travel and Lodging: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,360.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,330.00 |
| Food and Beverage | $2,677.70 |
| Travel and Lodging | $942.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $62,839.25 | 2019-2023 | Orilissa |
| Medical Device Business Services, INC. | $22,500.00 | 2019 | |
| Covidien LP | $8,576.24 | 2019-2020 | |
| Pfizer INC. | $5,552.59 | 2022-2024 | |
| Baxter Healthcare | $4,687.26 | 2019-2024 | Floseal, Tisseel |
| Hologic Sales and Service, LLC | $853.01 | 2020-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Arthrex, INC. | $253.00 | 2025 | |
| Sumitomo Pharma America, INC. | $201.88 | 2023-2024 | Myfembree |
| Medtronic, INC. | $163.72 | 2022-2025 | Truclear |
| Ferring Pharmaceuticals INC. | $159.07 | 2023-2025 | Menopur |
| Avanos Medical | $145.53 | 2019 | |
| Meditrina | $143.76 | 2024 | |
| Astellas Pharma Global Development | $116.63 | 2025 | Veozah |
| Organon LLC | $116.61 | 2021-2023 | Ganirelix Acetate, Follistim Aq |
| Gynesonics, INC. | $116.00 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $100.41 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $89.70 | 2023 | Exparel |
| Emd Serono, INC. | $73.49 | 2023-2025 | |
| Teleflex LLC | $72.68 | 2024 | Quikclot |
| Myovant Sciences INC. | $69.20 | 2021 | |
| Fujifilm Healthcare Americas Corporation | $66.02 | 2020 | |
| Karl Storz Endoscopy-America | $65.04 | 2019 | |
| Cook Medical LLC | $60.51 | 2022 | |
| Merck Sharp & Dohme LLC | $42.27 | 2019-2021 | |
| Tesaro, INC. | $39.35 | 2019 | |
| Ethicon US, LLC | $33.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Brotherton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.